In Vitro Diagnostics Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035
The global IVD market size is estimated to grow from $108 billion in 2024 to $190 billion by 2035, growing at a CAGR of 5.2% during the forecast period 2024 to 2035.
In vitro diagnostics domain encompasses a
variety of tests, which are categorized into four different classes based on
their risk; such solutions serve a diverse set of therapeutic areas.
In vitro diagnostics (IVD) are the tests
conducted on samples retrieved from human body, such as blood, saliva or tissue
in order to detect diseases or conditions. Such tests help diagnose, monitor,
and manage diseases, such as diabetes, infectious diseases, and cancer. The
common types of IVD tests include immunoassays, molecular diagnostics, and
clinical chemistry tests. Such tests play a crucial role in healthcare by
providing timely and accurate information for medical decision-making. IVD
solutions are essential tools for screening, diagnosing, and monitoring
diseases, ultimately contributing to improved patient outcomes and public
health.
In the following sections, we explore the
various therapeutic areas targeted by In Vitro Diagnostic Solutions.
Infectious Disease – In vitro diagnostic solutions can be used to diagnose a variety
of infectious diseases. For example, for HIV / AIDS, a variety of HIV antibody
tests and viral load detection tests are available in the domain. On the other
hand, for diseases, such as Hepatitis, a variety of surface antigen tests and
Hepatitis C antibody tests are available in the market.
Cancer Diagnostics – In vitro diagnostic solutions serve as critical tools for early
detection and management of oncological disorders. can be used to diagnose a
variety of infectious diseases. Some of the examples include HER2/neu tests and
estrogen receptor / progesterone receptor tests for breast cancer detection and
fecal occult tests for colorectal cancer.
Cardiovascular Diseases – In vitro diagnostic solutions find their application in the
diagnosis of various cardiovascular diseases. For example, cardiac biomarkers
and troponin tests, lipid profile and cholesterol / triglyceride tests.
Autoimmune Disorders – In vitro diagnostic solutions are equally essential for the
diagnosis of autoimmune diseases. For example, rheumatoid factor tests,
anti-cyclic citrullinated peptide tests and antinuclear antibody tests for
systemic lupus erythematosus.
Neurological Disorders – Many of the In vitro diagnostic solutions are pivotal in the
diagnosis and management of neurological disorders. Some of the examples
include amyloid beta (Aβ) protein tests and tau protein tests for Alzheimer's
disease and oligoclonal banding tests in cerebrospinal fluid for multiple
sclerosis.
Pregnancy and Fertility – In vitro diagnostic solutions find a variety of applications in
the areas of pregnancy and fertility. For example, urine-based hCG tests for
rapid pregnancy detection test, ovulation predictor kits and sperm analysis
tests.
Projected market opportunity is likely to
be well distributed among various end users engaged in this the domain, with
majority of the revenues coming in from the more developed global regions.
Currently, the highest share, in terms of
therapeutic areas, is captured by in vitro diagnostic solutions intended for
infectious diseases which capture majority of the market share in 2024. On the
other hand, the cardiology segment is anticipated to show the highest annual
growth rate of 5.6%, during the forecast period of 2024-2035.
Further, in terms of test type, the global
IVD market is categorized into laboratory and point-of-care testing. Currently,
the laboratory testing segment occupies the highest in vitro diagnostics market
share (85%) and is expected to stay dominant during the forecast period.
However, it is worth mentioning that the point-of-care testing segment is
expected to grow at a higher CAGR compared to laboratory testing market owing
to their ability to deliver rapid test results and offer improved convenience
and accessibility.
On the other hand, based on end users, the
market is segmented into hospitals, laboratories, and other end users. The
hospitals segment led the in vitro diagnostics market, capturing the largest
share in 2024. Further, this segment is anticipated to show an annual growth
rate of 5.5% during the forecast period and is expected to hold the majority
share of the market in the future, as well.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/in-vitro-diagnostics-market.html
About Roots Analysis
Roots
Analysis is a global leader in the pharma / biotech market research. Having
worked with over 750 clients worldwide, including Fortune 500 companies,
start-ups, academia, venture capitalists and strategic investors for more than
a decade, we offer a highly analytical / data-driven perspective to a network
of over 450,000 senior industry stakeholders looking for credible market
insights.
We
specialise in analysing areas which have lacked quality research so far or
require more focused understanding within the broader industry. All our reports
are structured in a way to enable the reader develop a thorough perspective on
the given subject. Apart from writing reports on identified areas, we also
provide bespoke research / consulting services dedicated to serve our clients
in the best possible way.
The
research efforts are driven by a global team. The leadership team brings a
wealth of experience within the sector. Their collective experience in
pharmaceutical / affiliated domains allows us to tackle various areas of
research in a structured way. We also regularly leverage our global network of
experts who hold senior leadership positions in reputed firms and organisations
worldwide.
Contact:
Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
Website:
https://www.rootsanalysis.com/
Comments
Post a Comment